Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Management Inc. Opaleye currently holds 2,858,657 shares of Imprimis Pharmaceuticals, Inc. (IMMY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Management Inc. Opaleye has been a net buyer of IMMY stock. They have purchased $45.2M and sold $22.8M worth of shares.
Management Inc. Opaleye's most recent insider trade was on Oct 5, 2026, when they purchased 1,694 shares at $2.06 per share.
Management Inc. Opaleye serves as Executive at Imprimis Pharmaceuticals, Inc. (IMMY). They have executed 392 insider transactions totaling $68.1M over their tenure at the company.
Management Inc. Opaleye holds the position of Executive at Imprimis Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Management Inc. Opaleye has shown a buying trading pattern, with $45.2M in total purchases and $22.8M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Management Inc. Opaleye was on Dec 30, 2025, when they purchased $1.5M worth of SLGL shares. This transaction involved 35,169 shares at $41.99 per share.
Management Inc. Opaleye currently owns 2,858,657 shares of Imprimis Pharmaceuticals, Inc. (IMMY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Management Inc. Opaleye's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Management Inc. Opaleye has 392 Form 4 filings on record as an insider at Imprimis Pharmaceuticals, Inc..
Set alerts for Management Inc. Opaleye and 40,000+ other insiders.